Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000902664-22-001605
Filing Date
2022-02-14
Accepted
2022-02-14 08:53:16
Documents
1

Document Format Files

Seq Description Document Type Size
1 ASLAN PHARMACEUTICALS LIMITED p22-0657sc13g.htm SC 13G 66230
  Complete submission text file 0000902664-22-001605.txt   67847
Mailing Address 40 10TH AVENUE 7TH FLOOR NEW YORK NY 10014
Business Address 40 10TH AVENUE 7TH FLOOR NEW YORK NY 10014 646-597-6980
RTW INVESTMENTS, LP (Filed by) CIK: 0001493215 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 83 CLEMENCEAU AVENUE #12-03 UE SQUARE SINGAPORE U0 239920
Business Address 83 CLEMENCEAU AVENUE #12-03 UE SQUARE SINGAPORE U0 239920 65 6222 4235
ASLAN Pharmaceuticals Ltd (Subject) CIK: 0001722926 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-91181 | Film No.: 22625787
SIC: 2834 Pharmaceutical Preparations